Search

Posts

By Biotech Mag   -   9 days ago

ONCTERNAL THERAPEUTICS REPORTS GRANTING OF AN INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(4)

SAN DIEGO, Feb. 22, 2021 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of...

Therapies, NASDAQ, Clinical, Therapeutics, News, Syndication, Nasdaq, ONCTUS68236P1075 More  
By Biotech Mag Top   -   3 monthes ago

ONCTERNAL ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

SAN DIEGO, Nov. 04, 2020 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of...

Therapeutics, Therapies, Clinical, News, Syndication, Nasdaq, ONCTUS68236P1075 More  
 
 
 

Pages